NEW
YORK, July 22, 2022 /PRNewswire/ -- Jakubowitz
Law announces that a securities fraud class action lawsuit has
commenced on behalf of shareholders of Apyx Medical Corporation
(NASDAQ: APYX).
To receive updates on the lawsuit, fill out the
form:
https://claimyourloss.com/securities/apyx-medical-corporation-loss-submission-form/?id=30079&from=4
The lawsuit seeks to recover losses for shareholders who
purchased Apyx between May 12, 2021
and March 11, 2022.
Shareholders interested in acting as a lead plaintiff
representing the class of wronged shareholders have until
August 5, 2022 to petition the
court. Your ability to share in any recovery doesn't require that
you serve as a lead plaintiff.
According to a filed complaint, Apyx Medical Corporation issued
materially false and/or misleading statements and/or failed to
disclose that: (1) a significant number of Apyx's Advanced Energy
products were used for off-label indications; (2) such off-label
uses led to an increase in the number of medical device reports
filed by Apyx reporting serious adverse events; (3) as a result,
the Company was reasonably likely to incur regulatory scrutiny; (4)
as a result of the foregoing, the Company's financial results would
be adversely impacted; and (5) as a result of the foregoing,
defendants' positive statements about the Company's business,
operations, and prospects were materially misleading and/or lacked
a reasonable basis.
Jakubowitz Law is vigorous in pursuit of justice for
shareholders who have been the victim of securities fraud. Attorney
advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
View original
content:https://www.prnewswire.com/news-releases/apyx-shareholder-alert-jakubowitz-law-reminds-apyx-shareholders-of-a-lead-plaintiff-deadline-of-august-5-2022-301591516.html
SOURCE Jakubowitz Law